A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03)
Clinical trial NCT06362252 · RECRUITING
Trial details
- NCT number
- NCT06362252
- Sponsor
- Daiichi Sankyo
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-22
- Primary completion
- 2026-09-30
- Enrollment
- 123
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.